NCT06734988 EXTEND ARDS-J Esophageal Pressure Study
| NCT ID | NCT06734988 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sapporo Medical University |
| Condition | ARDS (Acute Respiratory Distress Syndrome) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-12-04 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-12-04 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Acute respiratory distress syndrome (ARDS) patients require careful assessment before extubation to prevent failure, which is associated with poor outcomes. While current guidelines recommend weaning protocols, these are based on general respiratory failure studies rather than ARDS-specific data. Esophageal pressure (Pes) measurement provides direct assessment of inspiratory effort but is rarely utilized clinically. Objectives: This Japanese sub-study of EXTEND ARDS aims to evaluate whether: 1. ΔPes measurements during spontaneous breathing trials (SBT) can predict SBT failure 2. ΔPes measurements post-extubation can predict 48-hour extubation failure Methods: This prospective observational study will be conducted in Japanese ICUs. Esophageal pressure will be measured using standardized Nutrivent balloons (4mL volume) with Hamilton ventilators. Balloon placement in the lower third of the esophagus will be confirmed by cardiac artifacts and chest X-ray. ΔPes will be calculated as the difference between end-expiratory and peak inspiratory esophageal pressure, excluding esophageal contractions. Significance: This study addresses a knowledge gap regarding the utility of esophageal pressure monitoring in ARDS patients during mechanical ventilation weaning. Findings may help optimize extubation timing and improve patient outcomes through objective physiological measurements.
Eligibility Criteria
Inclusion Criteria: 1. Adult mechanically ventilated patients (≥ 16 years old) with esophageal pressure monitoring, expected to receive invasive mechanical ventilator for more than 48 hours 2. Patients who meet the diagnosis of ARDS at the start of invasive mechanical ventilation based on a new global definition of ARDS. Exclusion Criteria: 1. Patients who already had tracheostomy at the start of invasive mechanical ventilation 2. Patients who were transferred to participating hospital more than 2 days after the start of invasive mechanical ventilation 3. Patients with terminal conditions at the start of invasive mechanical ventilation 4. Patients who have expressed their refusal to have their clinical data used in research
Frequently Asked Questions
Who can join the NCT06734988 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying ARDS (Acute Respiratory Distress Syndrome). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734988 currently recruiting?
Yes, NCT06734988 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sapporo Medical University to inquire about joining.
Where is the NCT06734988 trial being conducted?
This trial is being conducted at Sapporo, Japan.
Who is sponsoring the NCT06734988 clinical trial?
NCT06734988 is sponsored by Sapporo Medical University. The trial plans to enroll 100 participants.